← Back to Search

Re-Connect App for Smoking Cessation

N/A

Recruiting

Led By Bethany Raiff, PhD

Research Sponsored by Rowan University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals who report smoking at least 10 cigarettes per day for at least 2 years and are 18 years of age or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if making people use an app to prove they're not smoking works to help them quit.

Who is the study for?

This trial is for adults who have smoked at least 10 cigarettes daily for over 2 years, want to quit smoking (strong desire), can use a smartphone, and speak English. They must not have health issues like severe lung conditions or unmanaged mental health problems.

What is being tested?

The study tests two methods using smartphone apps that reward quitting smoking: one restricts app access unless you prove you're smoke-free, while the other rewards abstinence with more app features.

What are the potential side effects?

There are no direct medical side effects since this trial involves behavior modification through technology rather than medication. However, participants may experience stress or frustration related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have smoked 10 cigarettes daily for 2+ years and am 18 or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

7-day point prevalence of self-reported, and CO verified, smoking

Acceptability (RCT, Aim 2)

Duration of Re-Connect Use (RCT, Aim 2)

+3 more

Secondary study objectives

Initial Acceptability

Other study objectives

Smartphone Use Moderators

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Abstinent Contingent (AC) Re-ConnectExperimental Treatment1 Intervention

Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).

Group II: Submission Contingent (SC) Re-ConnectActive Control1 Intervention

Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

0 / 1Eligibility criteria met